ClinicalTrials.gg
WithdrawnNCT05253586VOLAREUpdated Mar 12, 2025

Versius or Laparoscopic Abdominal Hernia REpair

An observational study in Abdominal Hernia and Abdominal Surgery, sponsored by Joanne Turner. Withdrawn. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2025-03-12.

Sponsored by Joanne Turner · Observational

Why this study was withdrawn
PhD studentship research defined area changed.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
0
Ages
18 Years to 100 Years
Sex
All
01

Study summary

This trial will compare laparoscopic and robotic-assisted abdominal hernia repairs, using the Versius® system. We will initially aim to recruit 60 patients (20 patients in the laparoscopic arm and 40 in the robotic arm) in order to assess the ergonomic impact of each modality on the operating surgeon. This aims to provide in vivo information on whether robotic surgery provides any advantages to the operating surgeon. This trial will also be used to assess the feasibility of recruitment to a future larger study, and any data collected will be used as pilot data.

Read the detailed description

This study has been designed to assess the ergonomics of Versius® assisted surgery in comparison with laparoscopic surgery in the management of abdominal hernias. The study will randomise 60 patients who require repair of an abdominal hernia and have been deemed suitable for a minimally invasive approach. Patients will be randomised to receive either laparoscopic or Versius® robotic assisted surgery but will be informed that it will be attempted via a minimally invasive approach that could include either of these two subtypes of minimally invasive surgery.

02

Conditions studied

  • Abdominal Hernia
  • Abdominal Surgery

Browse trials for

Keywords

  • ergonomics
  • robotics
  • versius
03

In context

Hernia, Abdominal

82 studies on the registry are indexed under Hernia, Abdominal; 19 are open to participants now.

Browse Hernia, Abdominal studies →

Lead sponsor

Joanne Turner is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pateints diagnosed with an abdominal hernia and are deemed suitable for minimally invasive surgery

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥18 years
  • Need for abdominal hernia repair surgery

    • Incisional
    • Congenital
  • Deemed suitable for minimally invasive surgery

Exclusion criteria

Exclusion Criteria:

  • Patients who are unable to consent
  • Prisoners
  • Patients in need of emergency surgery
  • Patients with a hernial defect size of over 7cm
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
0 participants (actual)
Patient registry
No

Groups and cohorts

  • Laparoscopic Arm

    This cohort of participants will have their procedure completed by a human surgeon.

    Procedure: Laparoscopic

  • Robotic Arm

    This cohort of participants will have their procedure completed by the Versius Surgical Robotic System.

    Procedure: Robotic

Interventions

  • ProcedureLaparoscopic

    Surgeon

  • ProcedureRobotic

    Versius system

06

What researchers measure

Primary outcomes

  1. To compare the operating surgeon ergonomics (physical strain) of laparoscopic and Versius® robotic assisted surgery

    body position (physical strain) and cognitive workload (mental strain) assessed using the REBA score

    Time frame: Length of the procedure expected to be between 1-4 hours

Secondary outcomes

  1. Measurement of the rate of participant recruitment

    Measure the number of participants recruited over the length of time. The units of measurement will be presented on a scale of number of participants over a predetermined length of time.

    Time frame: Through study completion, an average of 1 year.

  2. Measurement of drop-out (withdrawal) rate of participants

    Measure the number of participants who withdrawal (drop out) from the trial. The units of measurement will be presented on a scale of numbers of withdrawals versus time.

    Time frame: Assessed from Day 1 (Randomisation) to date of withdrawal

  3. Measurement of the unblinding rate of participants

    Measure the number of participants where the treatment is unblinded during the trial. This is measured by the number of participants over the length of time who's treatment is unblinded.

    Time frame: Through study completion, an average of 1 year.

  4. Mental strain of surgeon

    To compare the operating surgeon mental strain of each approach using the NASA-Task Load Index score.

    Time frame: 30 minutes maximum completion time per surgeon

  5. Health Economics

    Explore health economic aspects of each approach via calculation of the entire hospital episode and individual operation (including fixed costs and instrument costs) comparing the cost for cohort using the Versus Surgical Robot versus the human surgeon.

    Time frame: Procedure and recovery inpatient stay per participant expected to be between 1-3 days.

  6. Communication

    To compare differences in in-theatre communication assessed from audiovisual footage, using the Oxford NOTECHS II score.

    Time frame: 1-4 hours expected for the duration of the procedure

  7. Satisfaction with life scale

    Quality of life units completion of EQ-5D-5L questionnaire post operatively on day 14. Total scores used not sub scales to be reported.

    Time frame: Assessed on Day 14

  8. Satisfaction with life scale

    Quality of life units completion of MFSI-SF questionnaires post operatively on day 14. Total scores used not sub scales to be reported.

    Time frame: Assessed on Day 14

  9. Length of in-patient stay

    Measure of the time in days of each participant's hospital stay as an in-patient.

    Time frame: Up to 4 weeks

  10. Pain Scores

    Using a uni-dimensional pain score measurement examining the change from baseline.

    Time frame: Days 1, 2, 3, 14 and 28

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Mar 2024; primary completion for Mar 2024, 0 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 4, 2022
First posted
Feb 24, 2022
StartEst.
Mar 31, 2024
Primary completionEst.
Mar 31, 2024
CompletionEst.
Mar 31, 2024
Last update
Mar 12, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 12, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05253586
Lead sponsor
Joanne Turner
Responsible party
Joanne Turner (Academic Research Coordinator, Milton Keynes University Hospital NHS Foundation Trust) — Sponsor-investigator
First posted
Feb 24, 2022
Start date
Mar 31, 2024 (estimated)
Primary completion
Mar 31, 2024 (estimated)
Completion
Mar 31, 2024 (estimated)
Last update
Mar 12, 2025

Study contacts

Barrie Keeler
principal investigator · Consultant Colorectal Surgeon

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion